CSA Medical, a Baltimore developer of endoscopic cryoablation systems, raised $8.3 million in a first round of funding, VentureWire reports (subscription required). New Markets Growth Fund and angel investors provided the funding.
CSA Medical makes and sells a device it calls the CryoSpray Ablation system, which delivers a spray of liquid nitrogen via endoscope to freeze and remove cancerous and precancerous tissue inside the body.
Tags: co:CSA-Medical, cryoablation, deal, inv:New-Markets-Growth-Fund, medical-devices
Trackback URL
